Expression of concern

Inhibition of Tumor Angiogenesis by Tumstatin: Insights into Signaling Mechanisms and Implications in Cancer Regression

Expression of concern Details

Nature of Retraction:

Expression of concern

Retraction Notice:
10.1007/s11095-008-9634-z
Additional Notes:

Yakkanti Sudhakar has aka of Yakkanti Akul Sudhakar, Akulapalli Sudhakar, and Sudhakar Yakkanti; Sudhakar Yakkanti has ORI finding of misconduct; https://ori.hhs.gov/content/case-summary-yakkanti-sudhakar;

Citations (53)

53
Total Citations
6
Post-Retraction
(11.3%)
46
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
2 After 2+ years
1089 Days since retraction (latest)
Regulation of endothelial cell functions by basement membrane‐ and arachidonic acid‐derived products
Ambra Pozzi, Roy Zent
WIREs Systems Biology and Medicine Open Access
Published: May 2009
37 citations
4053 days before retraction
Validation of Different Systems for Tumstatin Expression and its in-vitro and iv-vivo Activities
Chandra S. Boosani, Anil Kumar Verma, Akulapalli Sudhakar
Journal of Cancer Science & Therapy Open Access
Published: Jan 2009
10 citations
4173 days before retraction
History of Cancer, Ancient and Modern Treatment Methods
Akulapalli Sudhakar
Journal of Cancer Science & Therapy Open Access
Published: Jan 2009
466 citations
4173 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #25562
Jan 15, 2021
Retraction
Quick Stats
Total Citations: 53
Years Since Retraction: 5.5 years
Open Access: Yes
Last Checked: Jul 24, 2025